EP3725317
PHARMACEUTICAL COMPOSITION COMPRISING ADENOSINE DERIVATIVE FOR PREVENTION AND TREATMENT OF RETINAL DISEASE OR OPTIC NERVE DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.11.2018EP published:
7.2.2024EP application number:
18883014.5
EPO information:
European Patent Register
Max expiry date:
28.11.2038
Title in English:
PHARMACEUTICAL COMPOSITION COMPRISING ADENOSINE DERIVATIVE FOR PREVENTION AND TREATMENT OF RETINAL DISEASE OR OPTIC NERVE DISEASELanguage of the patent:
English
Timeline
Today
29.11.2018EP application
7.2.2024EP Publication
Owner
Name:
Future Medicine Co., Ltd.Address:
(Siheung-dong) 616 LH Pangyo Business Growth Center 54 Changup-ro Sujeong-gu, Seongnam-si, Gyeonggi-do 13449, KR
Inventor
Name:
YANG, Jae WookAddress:
Busan 48099, KR
Name:
KIM, Jee YoungAddress:
Busan 49239, KR
Name:
LEE, Hyuk WooAddress:
Hwaseong-si Gyeonggi-do 18437, KR
Name:
PARK, Chong-WooAddress:
Seoul 05119, KR
Name:
YU, Mi RaAddress:
Seoul 08706, KR
Name:
LEE, Ji YounAddress:
Suwon-si Gyeonggi-do 16699, KR
Name:
PARK, Bo MiAddress:
Yongin-si Gyeonggi-do 17047, KR
Priority
Number:
20170161545Date:
29.11.2017Country:
KR
Classification
Categories:
A61K 31/52, A61K 31/7076, A61K 9/00, A61K 9/48, A61K 9/08, A61P 27/02, A61P 27/06